Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Genitourinary 4Gastrointestinal 4Sarcoma 3CNS 3Lymphoid 2Thoracic 1Other solid neoplasm 1

Conditions

Mesothelioma 53Advanced Solid Tumors 53Solid Tumor 51Advanced Solid Tumor 41Mesothelioma, Malignant 38Solid Tumors 35Unspecified Adult Solid Tumor, Protocol Specific 27Carcinoma, Non-Small-Cell Lung 25Retinoblastoma 14Melanoma 14Esophageal Neoplasms 14Solid Tumor, Adult 13Sarcoma 12Ovarian Neoplasms 12Lung Neoplasms 11Carcinoma, Renal Cell 11Uterine Cervical Neoplasms 10Small Cell Lung Carcinoma 10Stomach Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 7Pancreatic Neoplasms 7Neoplasm Metastasis 7Advanced Solid Tumours 7Neoplasms 6Urinary Bladder Neoplasms 5Thyroid Neoplasms 5Solitary Fibrous Tumor, Pleural 5Malignant Solid Tumor 5

Interventions

Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ovarian Germ Cell Cancer × Other solid neoplasm × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡